Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice

Lupus

Volumn 19, Issue 13, 2010, Pages 1502-1514

  Gu, Z ^a,b   Akiyama, K ^c   Ma, X ^a   Zhang, H ^a   Feng, X ^a   Yao, G ^a   Hou, Y ^d   Lu, L ^e   Gilkeson, G S ^f   Silver, R M ^f   Zeng, X ^g   Shi, S ^c   Sun, L ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NANJING UNIVERSITY   (China)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

high mobility group box 1; lupus nephritis; monocyte chemotactic protein 1; regulatory T cell; systemic lupus erythematosus; umbilical cord mesenchymal stem cell

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CREATININE; DOUBLE STRANDED DNA ANTIBODY; HIGH MOBILITY GROUP B1 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; KIDNEY; KIDNEY INJURY; LUNG; LUPUS ERYTHEMATOSUS NEPHRITIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; THERAPY EFFECT; UMBILICAL CORD;

ANIMALS; ANTIBODIES, ANTINUCLEAR; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHEMOKINE CCL2; CREATININE; FEMALE; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; LUPUS NEPHRITIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED MRL LPR; PROTEINURIA; UMBILICAL CORD;

EID: 78649245336     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310373782     Document Type: Article

References (52)

1. Marks SD, Williams SJ, Tullus K., Sebire N. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant 2008 ; 23: 3521-3526.
2. Wada T., Yokoyama H., Su SB, et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996 ; 49: 761-767.
3. Tesch GH, Maifert S., Schwarting A., Rollins BJ, Kelley VR Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 1999 ; 190: 1813-1824.
4. Perez de Lema G., Maier H., Nieto E., et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001 ; 12: 1369-1382.
5. Andersson U., Wang H., Palmblad K., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000 ; 192: 565-570.
6. Hayashi A., Nagafuchi H., Ito I., Hirota K., Yoshida M., Ozaki S. Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity. Mod Rheumatol 2009 ; 19: 283-292.
7. Hoffman RW T cells in the pathogenesis of systemic lupus erythematosus. Front Biosci 2001 ; 6: D1369-1378.
8. Chan OT, Madaio MP, Shlomchik MJ The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999 ; 169: 107-121.
9. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004 ; 22: 531-562.
10. Hsu WT, Suen JL, Chiang BL The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 2006 ; 145: 513-519.
11. Valencia X., Yarboro C., Illei G., Lipsky PE Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007 ; 178: 2579-2588.
12. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974 ; 17: 331-340.
13. Owen M., Friedenstein AJ Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988 ; 136: 42-60.
14. Prockop DJ Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 ; 276: 71-74.
15. Le Blanc K., Tammik L., Sundberg B., Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003 ; 57: 11-20.
16. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 ; 99: 3838-3843.
17. Glennie S., Soeiro I., Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005 ; 105: 2821-2827.
18. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003 ; 101: 3722-3729.
19. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003 ; 75: 389-397.
20. Corcione A., Benvenuto F., Ferretti E., et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006 ; 107: 367-372.
21. Aggarwal S., Pittenger MF Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 ; 105: 1815-1822.
22. Le Blanc K., Frassoni F., Ball L., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008 ; 371: 1579-1586.
23. Chen X., Armstrong MA, Li G. Mesenchymal stem cells in immunoregulation. Immunol Cell Biol 2006 ; 84: 413-421.
24. Chen L., Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008 ; 3: e1886.
25. Kunter U., Rong S., Djuric Z., et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006 ; 17: 2202-2212.
26. Sun L., Zhang H., Feng X., Hou Y., Lu L., Fan L. Abnormality of bone marrow-derived stem cells in patients with systemic lupus erythematosus. Lupus 2007 ; 16: 121-128.
27. Zhou K., Zhang H., Jin O., et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008 ; 5: 417-424.
28. Sun L., Akiyama K., Zhang H., et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009 ; 27: 1421-1432.
29. Rao MS, Mattson MP Stem cells and aging: expanding the possibilities. Mech Ageing Dev 2001 ; 122: 713-734.
30. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesissupportive function and other potentials. Haematologica 2006 ; 91: 1017-1026.
31. Sadanaga A., Nakashima H., Masutani K., et al. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice. Arthritis Rheum 2005 ; 52: 3987-3996.
32. Van Parijs L., Abbas AK Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996 ; 8: 355-361.
33. Theofilopoulos AN, Dixon FJ Murine models of systemic lupus erythematosus. Adv Immunol 1985 ; 37: 269-390.
34. Wang H., Yang H., Czura CJ, Sama AE, Tracey KJ HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001 ; 164: 1768-1773.
35. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005 ; 102: 11474-11479.
36. Li Y., Chen J., Zhang CL, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005 ; 49: 407-417.
37. Wu Y., Chen L., Scott PG, Tredget EE Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007 ; 25: 2648-2659.
38. Tian J., Avalos AM, Mao SY, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007 ; 8: 487-496.
39. Shimizu S., Nakashima H., Masutani K., et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. Rheumatology (Oxford) 2004 ; 43: 1121-1128.
40. Yamada S., Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta 2007 ; 375: 36-42.
41. Rovere-Querini P., Capobianco A., Scaffidi P., et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004 ; 5: 825-830.
42. Gardella S., Andrei C., Ferrera D., et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002 ; 3: 995-1001.
43. Scaffidi P., Misteli T., Bianchi ME Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002 ; 418: 191-195.
44. Taguchi A., Blood DC, del Toro G., et al. Blockade of RAGEamphoterin signalling suppresses tumour growth and metastases. Nature 2000 ; 405: 354-360.
45. Park JS, Gamboni-Robertson F., He Q., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006 ; 290: C917-924.
46. Desai-Mehta A., Mao C., Rajagopalan S., Robinson T., Datta SK Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995 ; 95: 531-541.
47. Uesugi H., Ozaki S., Sobajima J., et al. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol 1998 ; 25: 703-709.
48. Popovic K., Ek M., Espinosa A., et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005 ; 52: 3639-3645.
49. Deocharan B., Zhou Z., Antar K., et al. Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J Immunol 2007 ; 179: 1313-1321.
50. Crispin JC, Martinez A., Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003 ; 21: 273-276. (Pubitemid 37410115)
51. Carrion F., Nova E., Ruiz C., et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 2009 ; 19: 317-322.
52. Traggiai E., Volpi S., Schena F., et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008 ; 26: 562-569.